Inter Pharma Public Company Limited
IP
Rank in Stocks
#20211
Based in Bangkok, Thailand, Inter Pharma Public Company Limited specializes in... Based in Bangkok, Thailand, Inter Pharma Public Company Limited specializes in the manufacturing, importing, and distribution of a wide array of health and dietary supplements designed for both human and animal use. The company's operations are divided into two primary segments: Human Healthcare and Animal Healthcare. Its Human Healthcare division provides a diverse range of items including medical supplies, nutritional therapy products, cosmetics, supplemental foodstuffs, probiotic and prebiotic offerings, health-focused and general food products, medical devices, and pharmaceutical medicines. This segment also extends to wellness and anti-aging solutions, aesthetic treatments like anti-wrinkle creams, hyaluronic fillers, and EGF cosmeceuticals, as well as diagnostic tools. For the Animal Healthcare sector, Inter Pharma caters to pets and livestock with veterinary provisions, nutritional support, vaccines, supplementary feeds, probiotic and prebiotic formulations, specialized animal health foods, premium and standard animal feeds, nutraceuticals, medicated shampoos, animal cosmeceuticals, and general pet and livestock food products. The company was founded in 2006 and is headquartered in Bangkok.
Share Price
$0.14672635
Last synced: 2026-11-10
Market Cap
$88.82M
Change (1 day)
0.82%
Change (1 year)
18.59%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Inter Pharma Public Company Limited (IP)
Category
Healthcare
P/S ratio for Inter Pharma Public Company Limited (IP)
P/S ratio as of November 2026 TTM: 1.31
According to Inter Pharma Public Company Limited's latest financial reports and stock price, its current price-to-sales ratio (TTM) is 1.31. At the end of 2025 the company had a P/S ratio of 1.27.
P/S ratio history for Inter Pharma Public Company Limited from 2016 to 2026
P/S ratio at the end of each year
| Year | P/S Ratio | Change |
|---|---|---|
| 2026 (TTM) | 1.31 | 2.86% |
| 2025 | 1.27 | 23.58% |
| 2024 | 1.03 | -14.57% |
| 2023 | 1.20 | -38.59% |
| 2022 | 1.96 | -49.30% |
| 2021 | 3.86 | 20.29% |
| 2020 | 3.21 | 47.89% |
| 2019 | 2.17 | -6.29% |
| 2018 | 2.32 | -8.75% |
| 2017 | 2.54 | -49.28% |
| 2016 | 5.00 | 0.00% |
P/S ratio for similar companies or competitors
| Company | P/S Ratio | P/S Ratio Difference | Country |
|---|---|---|---|
| 11.22 | 758.98% |
US
|
|
| 39.73 | 2,941.42% |
US
|
|
| 4.30 | 229.50% |
AU
|
|
| 6.29 | 381.84% |
BE
|
|
| 12.68 | 870.61% |
NL
|
Questions about Inter Pharma Public Company Limited's P/S ratio
What is Inter Pharma Public Company Limited's P/S ratio?
Inter Pharma Public Company Limited's P/S ratio is 1.31, as of Nov 2026.
What was Inter Pharma Public Company Limited's P/S ratio in 2025?
In 2025, Inter Pharma Public Company Limited's P/S ratio was 1.27, compared with 1.03 in 2024.
How has Inter Pharma Public Company Limited's P/S ratio changed since 2020?
From 2020 to 2025, Inter Pharma Public Company Limited's P/S ratio was highest in 2021 (3.86) and lowest in 2024 (1.03).
How does Inter Pharma Public Company Limited's P/S ratio compare with similar companies?
Inter Pharma Public Company Limited's P/S ratio (1.31) is lower than that of all 5 similar companies listed above. The highest among them is Moderna, Inc., with 39.73.